Delving into the Latest Updates on PRT-042 with Synapse

Overview

Basic Info

Drug Type

Unknown

Synonyms

PRT-042

Target-

Action-

Mechanism-

Therapeutic Areas-

Active Indication-

Inactive Indication-

Originator Organization

Sichuan Purity Pharmaceutical Co., Ltd.

Active Organization-

Inactive Organization-

License Organization-

Drug Highest Phase-

First Approval Date-

Regulation-

Login to view timeline

The purpose of this study is to learn about:
* To evaluate the efficacy of PRT-042 nasal spray for the Rapid Reduction of the depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior
* To evaluate the safety and pharmacokinetic (PK) characteristics after multiple dose of PRT-042 nasal spray in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior

Start Date27 May 2025

Sponsor / Collaborator

Sichuan Purity Pharmaceutical Co., Ltd.

100 Clinical Results associated with PRT-042

Login to view more data

100 Translational Medicine associated with PRT-042

Login to view more data

100 Patents (Medical) associated with PRT-042

Login to view more data

100 Deals associated with PRT-042

Login to view more data